trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
von Hippel-Lindau Disease D006623 1 associated lipids
Intervertebral Disc Degeneration D055959 1 associated lipids
Supratentorial Neoplasms D015173 1 associated lipids
Hypesthesia D006987 1 associated lipids
Cystadenocarcinoma, Mucinous D018282 1 associated lipids
Myopathy, Central Core D020512 1 associated lipids
Roseolovirus Infections D019349 1 associated lipids
Thyroid Hormone Resistance Syndrome D018382 1 associated lipids
Chromosome Inversion D007446 1 associated lipids
Rhabdomyosarcoma, Embryonal D018233 1 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Kawano T et al. Depsipeptide enhances imatinib mesylate-induced apoptosis of Bcr-Abl-positive cells and ectopic expression of cyclin D1, c-Myc or active MEK abrogates this effect. 2004 Sep-Oct Anticancer Res. pmid:15517875
Fenic I et al. In vivo effects of histone-deacetylase inhibitor trichostatin-A on murine spermatogenesis. 2004 Sep-Oct J. Androl. pmid:15292114
Kook SH et al. Epstein-Barr virus-infected Akata cells are sensitive to histone deacetylase inhibitor TSA-provoked apoptosis. 2005 J. Biochem. Mol. Biol. pmid:16336792
Chen LJ et al. [hCG-PLZF-RARalpha/hCG-RARalpha-PLZF transgenic mice developing into leukemia]. 2005 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:16403252
Liu H et al. [Antineoplastic effect of valproic acid and trichostatin on HL-60 and K562 cells]. 2005 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:16403260
Chen J and Kang JH Quercetin and trichostatin A cooperatively kill human leukemia cells. 2005 Pharmazie pmid:16320950
Wei M et al. BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. 2005 Cancer Res. pmid:16322213
Marchion DC et al. Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIbeta. 2005 Clin. Cancer Res. pmid:16322310
Kasper LH et al. Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression. 2005 EMBO J. pmid:16237459
Columbaro M et al. Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment. 2005 Cell. Mol. Life Sci. pmid:16261260
Burlibaşa L and Gavrilă L Molecular and ultrastructural studies of the sperm chromatin from Triturus cristatus. 2005 Zygote pmid:16261764
Marengo E et al. Use of Legendre moments for the fast comparison of two-dimensional polyacrylamide gel electrophoresis maps images. 2005 J Chromatogr A pmid:16301071
Juranek SA et al. snRNA and heterochromatin formation are involved in DNA excision during macronuclear development in stichotrichous ciliates. 2005 Eukaryotic Cell pmid:16278460
Chang CW et al. Stimulation of GCMa transcriptional activity by cyclic AMP/protein kinase A signaling is attributed to CBP-mediated acetylation of GCMa. 2005 Mol. Cell. Biol. pmid:16166624
Jori FP et al. RB and RB2/p130 genes demonstrate both specific and overlapping functions during the early steps of in vitro neural differentiation of marrow stromal stem cells. 2005 Cell Death Differ. pmid:15459751
Hammond SM et al. Negative regulatory elements are present in the human LMO2 oncogene and may contribute to its expression in leukemia. 2005 Leuk. Res. pmid:15541480
Chang S and Pikaard CS Transcript profiling in Arabidopsis reveals complex responses to global inhibition of DNA methylation and histone deacetylation. 2005 J. Biol. Chem. pmid:15516340
Johnson J et al. Fetal hemoglobin induction by the histone deacetylase inhibitor, scriptaid. 2005 Cell. Mol. Biol. (Noisy-le-grand) pmid:16171558
Karagiannis TC et al. The histone deacetylase inhibitor, Trichostatin A, enhances radiation sensitivity and accumulation of gammaH2A.X. 2005 Cancer Biol. Ther. pmid:16082178
Xiong Y et al. Epigenetic-mediated upregulation of progesterone receptor B gene in endometrial cancer cell lines. 2005 Gynecol. Oncol. pmid:16024066
Xu CR et al. Histone acetylation affects expression of cellular patterning genes in the Arabidopsis root epidermis. 2005 Proc. Natl. Acad. Sci. U.S.A. pmid:16176989
Wu P et al. Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor. 2005 Biochem. Biophys. Res. Commun. pmid:16051188
Yaneva M et al. Non-homologous end joining, but not homologous recombination, enables survival for cells exposed to a histone deacetylase inhibitor. 2005 Nucleic Acids Res. pmid:16177181
Kang JE et al. Histone deacetylase-1 represses transcription by interacting with zinc-fingers and interfering with the DNA binding activity of Sp1. 2005 Cell. Physiol. Biochem. pmid:16121030
Chen CS et al. Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes. 2005 J. Biol. Chem. pmid:16186112
Bradbury CA et al. Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. 2005 Leukemia pmid:16121216
Cismasiu VB et al. BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter. 2005 Oncogene pmid:16091750
Fang MZ et al. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. 2005 Clin. Cancer Res. pmid:16203797
García-Morales P et al. Histone deacetylase inhibitors induced caspase-independent apoptosis in human pancreatic adenocarcinoma cell lines. 2005 Mol. Cancer Ther. pmid:16093438
Menegola E et al. Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity. 2005 Birth Defects Res. B Dev. Reprod. Toxicol. pmid:16193500
Nome RV et al. Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death. 2005 Mol. Cancer Ther. pmid:16093439
Liu AL et al. [A new target of cancer therapy: advances in the study of histone deacetylase]. 2005 Yao Xue Xue Bao pmid:16196262
Zhang Y et al. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. 2005 Mol. Cell. Biol. pmid:16135786
Ren C et al. Peptide mass mapping of acetylated isoforms of histone H4 from mouse lymphosarcoma cells treated with histone deacetylase (HDACs) inhibitors. 2005 J. Am. Soc. Mass Spectrom. pmid:16099169
Shinji C et al. Design and synthesis of phthalimide-type histone deacetylase inhibitors. 2005 Bioorg. Med. Chem. Lett. pmid:16137884
Danaher RJ et al. Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript-independent manner in neuronal cells. 2005 J. Neurovirol. pmid:16036811
Laribee RN and Klemsz MJ Histone H4 HDAC activity is necessary for expression of the PU.1 gene. 2005 Biochim. Biophys. Acta pmid:16139904
Blagosklonny MV et al. Depletion of mutant p53 and cytotoxicity of histone deacetylase inhibitors. 2005 Cancer Res. pmid:16103091
Choi JH et al. Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice. 2005 Arterioscler. Thromb. Vasc. Biol. pmid:16141407
Krouwels IM et al. A glue for heterochromatin maintenance: stable SUV39H1 binding to heterochromatin is reinforced by the SET domain. 2005 J. Cell Biol. pmid:16103223
Ishihara K [Role of eosinophils in allergic inflammation]. 2005 Yakugaku Zasshi pmid:16141691
Lu Q et al. Structure-based optimization of phenylbutyrate-derived histone deacetylase inhibitors. 2005 J. Med. Chem. pmid:16107152
Yanada M et al. Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines. 2005 Oncol. Rep. pmid:16142337
Uchida H et al. Histone deacetylase inhibitors induce differentiation of human endometrial adenocarcinoma cells through up-regulation of glycodelin. 2005 Endocrinology pmid:16123169
Su M et al. Recruitment of nuclear factor Y to the inverted CCAAT element (ICE) by c-Jun and E1A stimulates basal transcription of the bone sialoprotein gene in osteosarcoma cells. 2005 J. Biol. Chem. pmid:16087680
Somech R et al. The nuclear-envelope protein and transcriptional repressor LAP2beta interacts with HDAC3 at the nuclear periphery, and induces histone H4 deacetylation. 2005 J. Cell. Sci. pmid:16129885
Cho HH et al. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors. 2005 J. Cell. Biochem. pmid:16088945
Gurvich N et al. Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo. 2005 FASEB J. pmid:15901671
Gan Y et al. Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase. 2005 J. Biol. Chem. pmid:15722551
Endo M et al. Novel gender-related regulation of CYP2C12 gene expression in rats. 2005 Mol. Endocrinol. pmid:15661834
Sengupta S et al. Tumor suppressor p53 represses transcription of RECQ4 helicase. 2005 Oncogene pmid:15674334
Busson M et al. Coactivation of nuclear receptors and myogenic factors induces the major BTG1 influence on muscle differentiation. 2005 Oncogene pmid:15674337
Wen J et al. Tal1/SCL binding to pericentromeric DNA represses transcription. 2005 J. Biol. Chem. pmid:15677454
Illi B et al. Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress. 2005 Circ. Res. pmid:15705964
Jalonen U et al. Inhibition of tristetraprolin expression by dexamethasone in activated macrophages. 2005 Biochem. Pharmacol. pmid:15710351
Schmittwolf C et al. In vivo haematopoietic activity is induced in neurosphere cells by chromatin-modifying agents. 2005 EMBO J. pmid:15660132
Kang J et al. Antioxidants and trichostatin A synergistically protect against in vitro cytotoxicity of Ni2+ in human hepatoma cells. 2005 Toxicol In Vitro pmid:15649630
Peltonen K et al. Melanoma cell lines are susceptible to histone deacetylase inhibitor TSA provoked cell cycle arrest and apoptosis. 2005 Pigment Cell Res. pmid:15892716
Schwahn DJ et al. Dynamic regulation of the human dopachrome tautomerase promoter by MITF, ER-alpha and chromatin remodelers during proliferation and senescence of human melanocytes. 2005 Pigment Cell Res. pmid:15892717
Ranganathan P and Rangnekar VM Exploiting the TSA connections to overcome apoptosis-resistance. 2005 Cancer Biol. Ther. pmid:15908800
Rincón-Arano H et al. YY1 and GATA-1 interaction modulate the chicken 3'-side alpha-globin enhancer activity. 2005 J. Mol. Biol. pmid:15913647
Law RD and Suttle JC Chromatin remodeling in plant cell culture: patterns of DNA methylation and histone H3 and H4 acetylation vary during growth of asynchronous potato cell suspensions. 2005 Plant Physiol. Biochem. pmid:15922608
Seo H et al. Rapid generation of specific antibodies by enhanced homologous recombination. 2005 Nat. Biotechnol. pmid:15924134
Song Y et al. [The mechanisms of p21WAF1/Cip-1 expression in MOLT-4 cell line induced by TSA]. 2005 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:15854272
Xu ZM et al. [Analysis of the methylation in the promoter of LRP15 gene and its expression]. 2005 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:15854274
Mai A et al. Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides. 2005 J. Med. Chem. pmid:15857140
Ho WC et al. Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells. 2005 Cancer Res. pmid:15899819
Tran T et al. Enhancement of folate receptor alpha expression in tumor cells through the glucocorticoid receptor: a promising means to improved tumor detection and targeting. 2005 Cancer Res. pmid:15899836
Camelo S et al. Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. 2005 J. Neuroimmunol. pmid:15885809
Young DA et al. Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression. 2005 FEBS J. pmid:15819885
Canes D et al. Histone deacetylase inhibitors upregulate plakoglobin expression in bladder carcinoma cells and display antineoplastic activity in vitro and in vivo. 2005 Int. J. Cancer pmid:15499627
Yamaguchi K et al. Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2. 2005 J. Biol. Chem. pmid:15994313
Zhao XY et al. Granulocyte-macrophage colony-stimulating factor induces de novo methylation of the p15 CpG island in hematopoietic cells. 2005 Cytokine pmid:15996479
Sato N et al. Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling. 2005 Clin. Cancer Res. pmid:16000561
Munshi A et al. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. 2005 Clin. Cancer Res. pmid:16000590
Sng JC et al. Inhibition of histone deacetylation by trichostatin A intensifies the transcriptions of neuronal c-fos and c-jun genes after kainate stimulation. 2005 Neurosci. Lett. pmid:16002216
Shetty S et al. Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1. 2005 Mol. Cell. Biol. pmid:15964798
Place RF et al. HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha. 2005 Biochem. Pharmacol. pmid:15950952
Wooten LG and Ogretmen B Sp1/Sp3-dependent regulation of human telomerase reverse transcriptase promoter activity by the bioactive sphingolipid ceramide. 2005 J. Biol. Chem. pmid:15951564
Malago JJ et al. Anti-inflammatory properties of heat shock protein 70 and butyrate on Salmonella-induced interleukin-8 secretion in enterocyte-like Caco-2 cells. 2005 Clin. Exp. Immunol. pmid:15958071
Endo T et al. Changes in histone modifications during in vitro maturation of porcine oocytes. 2005 Mol. Reprod. Dev. pmid:15736133
Fan S et al. Valproic acid enhances gene expression from viral gene transfer vectors. 2005 J. Virol. Methods pmid:15737413
Xu S et al. Abrogation of DUSP6 by hypermethylation in human pancreatic cancer. 2005 J. Hum. Genet. pmid:15824892
Strait KA et al. Histone deacetylase inhibitors induce G2-checkpoint arrest and apoptosis in cisplatinum-resistant ovarian cancer cells associated with overexpression of the Bcl-2-related protein Bad. 2005 Mol. Cancer Ther. pmid:15827334
Magner WJ and Tomasi TB Apoptotic and necrotic cells induced by different agents vary in their expression of MHC and costimulatory genes. 2005 Mol. Immunol. pmid:15829293
Hu J and Colburn NH Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding. 2005 Mol. Cancer Res. pmid:15755876
Koh SH et al. Co-culture of human CD34+ cells with mesenchymal stem cells increases the survival of CD34+ cells against the 5-aza-deoxycytidine- or trichostatin A-induced cell death. 2005 Biochem. Biophys. Res. Commun. pmid:15752760
Mori T et al. Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. 2005 Cancer Res. pmid:15753377
Dowling M et al. Mitotic spindle checkpoint inactivation by trichostatin a defines a mechanism for increasing cancer cell killing by microtubule-disrupting agents. 2005 Cancer Biol. Ther. pmid:15753652
Dote H et al. Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour. 2005 Br. J. Cancer pmid:15770214
Laberge RM and Boissonneault G On the nature and origin of DNA strand breaks in elongating spermatids. 2005 Biol. Reprod. pmid:15772260
McKenzie GJ et al. Nuclear Ca2+ and CaM kinase IV specify hormonal- and Notch-responsiveness. 2005 J. Neurochem. pmid:15773917
Blais M et al. Synergy between deacetylase inhibitors and IL-1beta in activation of the serum amyloid A2 gene promoter. 2005 DNA Cell Biol. pmid:15812237
Sato N et al. Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. 2005 Oncogene pmid:15592528
Davidson SM et al. The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells but is specific to the hypertrophic effect of urocortin. 2005 Chembiochem pmid:15593114
Maxhimer JB et al. Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein kinase C inhibitor (calphostin C). 2005 J. Thorac. Cardiovasc. Surg. pmid:15632825
Kondo T et al. Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma. 2005 Oncogene pmid:15637589
Senawong T et al. BCL11A-dependent recruitment of SIRT1 to a promoter template in mammalian cells results in histone deacetylation and transcriptional repression. 2005 Arch. Biochem. Biophys. pmid:15639232
Nambiar MP et al. Transcriptional induction of cholinesterase expression and protection against chemical warfare nerve agents. 2005 Chem. Biol. Interact. pmid:16429504
Zhao Y et al. Histone acetylation regulates both transcription initiation and elongation of hsp22 gene in Drosophila. 2005 Biochem. Biophys. Res. Commun. pmid:15607742